With the global population prevalence of diabetes surpassing 463 million cases in 2019 and diabetes leading to millions of deaths each year, there is a critical need for feasible, rapid, and non-invasive methodologies for continuous blood glucose monitoring in contrast to the current procedures that are either invasive, complicated, or expensive. Breath analysis is a viable methodology for non-invasive diabetes management owing to its potential for multiple disease diagnoses, the nominal requirement of sample processing, and immense sample accessibility; however, the development of functional commercial sensors is challenging due to the low concentration of volatile organic compounds (VOCs) present in exhaled breath and the confounding factors influencing the exhaled breath profile. Given the complexity of the topic and the skyrocketing spread of diabetes, a multifarious review of exhaled breath analysis for diabetes monitoring is essential to track the technological progress in the field and comprehend the obstacles in developing a breath analysis-based diabetes management system. In this review, we consolidate the relevance of exhaled breath analysis through a critical assessment of current technologies and recent advancements in sensing methods to address the shortcomings associated with blood glucose monitoring. We provide a detailed assessment of the intricacies involved in the development of non-invasive diabetes monitoring devices. In addition, we spotlight the need to consider breath biomarker clusters as opposed to standalone biomarkers for the clinical applicability of exhaled breath monitoring. We present potential VOC clusters suitable for diabetes management and highlight the recent buildout of breath sensing methodologies, focusing on novel sensing materials and transduction mechanisms. Finally, we portray a multifaceted comparison of exhaled breath analysis for diabetes monitoring and highlight remaining challenges on the path to realizing breath analysis as a non-invasive healthcare approach.
This paper reports on hydrogen sensing based graphene oxide hybrid with Co-based metal organic frameworks (Co-MOFs@GO) prepared by the hydrothermal process. The texture and morphology of the hybrid were characterized by powder x-ray diffraction, scanning electron microscopy and Brunauer–Emmett–Teller analysis. Porous flower like structures assembled from Co-MOFs and GO flakes with sufficient specific surface area are obtained, which are ideal for gas molecules diffusion and interactions. Sensing performance of Co-MOFs@GO were tested and also improved by sputtering platinum (Pt) as a catalyst. The Pt-sputtered Co-MOFs@GO show outstanding hydrogen resistive-sensing with response and recovery times below 12 s at 15 °C. Also, they show stable, repeatable and selective responses to the target gas which make it suitable for the development of a high performance hydrogen sensor.
Early detection of wound infections is critical for timely intervention and prevention of possible complications since prompt treatment can help lower pathogen spread and enhance faster healing. Early detection also helps reduce the risk of serious infections requiring extensive medical interventions or life-threatening diseases such as sepsis. Culture-based approaches currently used for bacterial identification have limited sensitivity and specificity. At the same time, they are time-consuming, resulting in delays in therapy and, therefore, having a negative impact on the treatment outcomes. Quantifying the volatile organic compounds (VOCs) released by bacteria residing in wounds is a promising, non-invasive option for detecting infections at early stages. This method allows for continuous monitoring without requiring invasive procedures, thereby reducing patient discomfort and the risk of further complications. Spectroscopy methods and sensors are the primary VOC detection and quantification approaches, but sensors are more rapid, cost-effective, non-invasive, and precise. This review highlights the significance of the early detection of wound infection to enable timely intervention and prevent complications, emphasizing the limitations of culture-based approaches. It also explores the potential of quantifying VOCs using different methods and discusses the correlation between their levels and the rate of bacterial infections in wounds. Additionally, the review evaluates current VOC-based monitoring methods for wound management, identifies gaps in the field, and advocates for further research to advance wound care and enhance patient outcomes.
Microplastics as micropollutants are widely spread in aquatic areas that can have a toxic effect on aquatic life. To reduce the potential risk they pose, it is essential to detect the microplastics and the source of the contamination of the environment. Here, we designed and developed a droplet-based microfluidic impedance flow cytometer for in situ detection of microplastics in water. Impedance spectroscopy enables the direct measurement of the electrical features of microplastics as they move in water, allowing for sizing and identification of concentration. To show the feasibility of the developed method, pure and functionalized polystyrene beads ranging from 500 nm to 6 μm in four size groups and different concentrations were used. Focusing on three different frequencies (4.4 MHz, 11 MHz, and 22.5 MHz), the changes in the signal phase at frequencies of 4.4 MHz and 11 MHz are a strong indicator of microplastic presence. In addition, the functionalized microplastics showed different magnitudes of the measured signal phase than the pure ones. A k-nearest neighbors classification model demonstrated our developed system’s impressive 97.4% sensitivity in accurately identifying microplastics based on concentration. The equivalent circuit model revealed that the double-layer capacity of water droplets is significantly impacted by the presence of the microplastics. Our findings show the potential of droplet-based microfluidic impedance flow cytometry as a practical method for detecting microplastics in water.